Topic: Pharmaceutical Research And Manufacturers Of America
Washington, D.C. (Nov. 3, 2010) - Pharmaceutical and Manufacturers of America (PhRMA) Associate Vice President for Scientific & Regulatory Affairs Marie A. Vodicka testified today at the Food and Drug Administration's public hearing on federal implementation of the new biosimilars approval pathway.. ...
How relationships with industry may influence physician decisions is not just a concern limited to Capitol Hill or medical ethics committees. "This should be considered a wake-up call for physicians," said Adriane Fugh-Berman, MD, director of PharmedOut, a project founded with a ...
Washington, D.C. - Pharmaceutical and Manufacturers of America (PhRMA) today announced that John J. Castellani will assume the role of President and Chief Executive Officer, effective September 1, 2010. Mr. Castellani joins PhRMA after more than nine years as President and CEO ...
Washington, D.C. - Pharmaceutical and Manufacturers of America (PhRMA) today announced that John J. Castellani will assume the role of President and Chief Executive Officer, effective September 1, 2010. Mr. Castellani joins PhRMA after more than nine years as President and CEO ...
U.S. pharmaceutical companies released a report Tuesday, saying they are currently developing 234 medicines for the special healthcare needs of children.. The report from the trade group PhRMA, the Pharmaceutical Research and Manufacturers of America, was unveiled at Trinity Medical Center in ...
Jeffrey B. Kindler, Chairman and Chief Executive Officer, Pfizer, was elected board chairman of the Pharmaceutical and Manufacturers of America (PhRMA) today at the trade association's annual meeting. Mr. Kindler succeeds David R. Brennan, Chief Executive Officer and Executive Director of AstraZeneca, ...
Washington, D.C. - Pharmaceutical and Manufacturers of America (PhRMA) Senior Vice President David E. Wheadon issued the following statement regarding patients' access to reliable health information online: To that end, PhRMA is proposing that the Food and Drug Administration (FDA) issue new ...
Minnesota lawmakers plan to go after the pharmaceutical industry's relationship with doctors again this year, according to proposals outlined Monday. Minnesota was among the first states to require drug companies to report payments to doctors for lectures, consulting, research and other services, ...
Minnesota lawmakers plan to go after the pharmaceutical industry's relationship with doctors again this year, according to proposals outlined Monday.The proposals include legislation to block drug companies' access to physicians' prescribing data for marketing purposes. The third bill would tighten an existing ...
As the need for health care assistance mounts in Haiti after last week's catastrophic earthquake, America's pharmaceutical research and biotechnology companies continue to provide help. "The day the news broke about the tragedy in Haiti, America's biopharmaceutical companies got to work -- ...
Photo Gallery
From Around the Web
Video Gallery
-
Learn About New HIV AIDs Medicines ...
Watch HIV AIDs Medicines in Development: Getting to Zero. In ...2011-12-07 -
Lilly Researcher Shares Story on Alzheimers
Dr. Jan Lundberg, PH.D., executive VP science & technology and ...2012-01-26 -
PhRMA President & CEO John J. Castellani ...
Pharmaceutical Research and Manufacturers of America (PhRMA) President & CEO John ...2011-12-21
